110 reports of this reaction
3.6% of all PHOSPHORIC ACID reports
#4 most reported adverse reaction
MOBILITY DECREASED is the #4 most commonly reported adverse reaction for PHOSPHORIC ACID, manufactured by BM Private Limited. There are 110 FDA adverse event reports linking PHOSPHORIC ACID to MOBILITY DECREASED. This represents approximately 3.6% of all 3,032 adverse event reports for this drug.
Patients taking PHOSPHORIC ACID who experience mobility decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MOBILITY DECREASED is moderately reported among PHOSPHORIC ACID users, representing a notable but not dominant share of adverse events.
In addition to mobility decreased, the following adverse reactions have been reported for PHOSPHORIC ACID:
The following drugs have also been linked to mobility decreased in FDA adverse event reports:
MOBILITY DECREASED has been reported as an adverse event in 110 FDA reports for PHOSPHORIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
MOBILITY DECREASED accounts for approximately 3.6% of all adverse event reports for PHOSPHORIC ACID, making it a notable side effect.
If you experience mobility decreased while taking PHOSPHORIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.